Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Saliva Test Detects GHB and Alcohol Poisonings

By LabMedica International staff writers
Posted on 19 Jan 2016
A saliva-based test has been developed that offers the potential to screen for poisons commonly associated with the cheap or imitation manufacture of alcohol, and γ-hydroxybutyric acid, the so-called “date rape” drug GHB.

Treatment of poisoning from the consumption of ethanol and the management of the intoxicated patient represents a significant burden on many health services. More...
Further, poisoning from the consumption of other alcohols, notably methanol and ethylene glycol, occurs sporadically and from time to time outbreaks occur where food, drink or medicines are contaminated, resulting in significant mortality.

Scientists at Loughborough University (UK) and the University of Cordoba (Spain) added to the fresh saliva of volunteers and used a polydimethylsiloxane (PDMS) oral sampler to extract methanol, ethanol, ethylene glycol, 1,3-propandiol and γ-hydroxybutyric acid. The compounds were detected using gas chromatography-differential mobility spectrometry (GC-DMS). The extracted compounds were recovered by thermal desorption, isolated by gas chromatography and detected with differential mobility spectrometry, operating with a programmed dispersion field.

Calibration of the DMS under optimized conditions was undertaken using gas chromatography to introduce known on-column masses of the analytes injected in a solution of dichloromethane. The DMS used in the study was a planar device (SDP-1, Sionex Corporation, Bedford, MA, USA). Once the analytes had been added, the saliva standards were homogenized. Immediately after this had been done, a PDMS-coated titanium cartridge was removed from its sealed thermal desorption tube and placed into the vial, which was then sealed immediately.

C.L. Paul Thomas, PhD, a professor of Analytical Science, and coauthor of the study, said, “Many people attending accident and emergency departments have some kind of alcohol-related issue, particularly at the weekends. We're aiming to develop a test that is as simple as taking temperature with a thermometer that detects when patients are more than just drunk. We were surprised at the ease at which we could detect γ-hydroxybutyric acid. It's both a polar and acidic molecule, but it turned out to be easy to detect, even at the low concentrations we were studying.” The scientists are now working on running trials of their test in a clinical setting, on patients in emergency departments. The study was published on January 8, 2016, in the Journal of Breath Research.

Related Links:

Loughborough University 
University of Cordoba 




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.